156 related articles for article (PubMed ID: 12824891)
1. MeCP2 and promoter methylation cooperatively regulate E-cadherin gene expression in colorectal carcinoma.
Darwanto A; Kitazawa R; Maeda S; Kitazawa S
Cancer Sci; 2003 May; 94(5):442-7. PubMed ID: 12824891
[TBL] [Abstract][Full Text] [Related]
2. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
3. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
4. Loss of galectin-3 expression in mucinous colorectal carcinomas is associated with 5'CpG island methylation in Tunisian patients.
Mahmoud LK; Arfaoui A; Khiari M; Chaar I; El Amine O; Hmida AM; Gharbi L; Mzabi SR; Bouraoui S
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):258-65. PubMed ID: 21494181
[TBL] [Abstract][Full Text] [Related]
5. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells.
Tsao SW; Liu Y; Wang X; Yuen PW; Leung SY; Yuen ST; Pan J; Nicholls JM; Cheung AL; Wong YC
Eur J Cancer; 2003 Mar; 39(4):524-31. PubMed ID: 12751385
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas.
Garinis GA; Menounos PG; Spanakis NE; Papadopoulos K; Karavitis G; Parassi I; Christeli E; Patrinos GP; Manolis EN; Peros G
J Pathol; 2002 Dec; 198(4):442-9. PubMed ID: 12434413
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of HGF and its receptor in human colorectal cancer.
Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of CD44v6 in colorectal carcinomas is associated with hypermethylation of the CD44 promoter region.
Stallmach A; Wittig BM; Kremp K; Goebel R; Santourlidis S; Zeitz M; Menges M; Raedle J; Zeuzem S; Schulz WA
Exp Mol Pathol; 2003 Jun; 74(3):262-6. PubMed ID: 12782013
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
[TBL] [Abstract][Full Text] [Related]
10. Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.
Ichimura N; Shinjo K; An B; Shimizu Y; Yamao K; Ohka F; Katsushima K; Hatanaka A; Tojo M; Yamamoto E; Suzuki H; Ueda M; Kondo Y
Cancer Prev Res (Phila); 2015 Aug; 8(8):702-11. PubMed ID: 26063725
[TBL] [Abstract][Full Text] [Related]
11. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
12. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
[TBL] [Abstract][Full Text] [Related]
13. [E-cadherin promoter methylation and demethylation in epithelial ovarian carcinoma cells].
Qu PP; Shi Z; Li N
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):538-41. PubMed ID: 19957556
[TBL] [Abstract][Full Text] [Related]
14. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues.
Okudaira K; Kakar S; Cun L; Choi E; Wu Decamillis R; Miura S; Sleisenger MH; Kim YS; Deng G
Int J Oncol; 2010 Apr; 36(4):765-75. PubMed ID: 20198318
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
16. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
Nguyen CT; Gonzales FA; Jones PA
Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
[TBL] [Abstract][Full Text] [Related]
17. [Hypomethylation of 5'CpG island of insulin-like growth factor binding protein-related protein 1 is associated with its overexpression in colorectal cancer].
Lin J; Zhu YM; Shao LN; Huang Q; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):512-6. PubMed ID: 19094461
[TBL] [Abstract][Full Text] [Related]
18. Signet ring cell differentiation in mucinous colorectal carcinoma.
Börger ME; Gosens MJ; Jeuken JW; van Kempen LC; van de Velde CJ; van Krieken JH; Nagtegaal ID
J Pathol; 2007 Jul; 212(3):278-86. PubMed ID: 17471475
[TBL] [Abstract][Full Text] [Related]
19. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region.
Kanazawa T; Watanabe T; Kazama S; Tada T; Koketsu S; Nagawa H
Int J Cancer; 2002 Nov; 102(3):225-9. PubMed ID: 12397640
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.
Zhang CY; Mao L; Li L; Tian Z; Zhou XJ; Zhang ZY; Li J
Cancer; 2007 Jul; 110(1):87-95. PubMed ID: 17520682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
